ALK and lung carcinoma: On the other hand, Danilo Maddalo et al. induced chromosomal rearrangements using the virus-mediated CRISPR-Cas9 system to express the Eml4-Alk fusion gene, generating a mouse model of Eml4-Alk-driven lung cancer that responded to treatment with ALK –inhibitors [56].